Pregnancy is a physiological state of transient, reversible insulin resistance accompanied by major adaptations in glucose and lipid metabolism. Although placental hormones are key drivers of gestational insulin resistance, the mechanisms responsible for the rapid restoration of insulin sensitivity after delivery remain unclear. This review presents a dual-axis model in which fibroblast growth factor 21 (FGF21) and sex hormone–binding globulin (SHBG) represent complementary hepatic pathways regulating maternal metabolic plasticity. During late pregnancy, FGF21 may function as a metabolic resilience factor by promoting fatty acid oxidation, limiting lipid overload, and supporting mitochondrial flexibility through AMPK–PPARα signaling. Reduced SHBG, in contrast, may reflect hepatic insulin resistance and altered HNF4α-dependent transcription. After delivery, restoration of the HNF4α–SHBG axis may indicate recovery of hepatic insulin responsiveness, while persistent adaptive FGF21 signaling may facilitate metabolic reprogramming. Postpartum metabolic resetting may therefore represent an actively regulated process rather than a passive consequence of placental hormone withdrawal. Disruption of FGF21- and SHBG-mediated pathways may contribute to persistent insulin resistance and increased cardiometabolic risk after gestational diabetes. Understanding hepatokine-mediated regulation of maternal metabolic flexibility may provide new insights into risk stratification, early biomarkers, and therapeutic targets for the prevention of type 2 diabetes after pregnancy.
Background/Objectives: Successful and sustained breastfeeding depends on maternal, psychological, metabolic and obstetric factors including hydration status, body composition, gestational age at delivery and mode of delivery, which are rarely assessed together in routine postpartum care. Bioelectrical impedance analysis (BIA) provides a non-invasive assessment of hydration and tissue composition, yet its potential to support lactation outcomes remains insufficiently studied. This study aimed to evaluate the relationship between postpartum body composition, hydration status assessed with BIA, and breastfeeding duration. Methods: A total of 122 women in the early postpartum period after term singleton deliveries were enrolled, of whom 50 completed the full protocol, including a 7-month follow-up. BIA and anthropometric measurements were performed on postpartum days 2 and 3. Breastfeeding duration was assessed at 7 months via telephone interview and categorized as <6 months or ≥6 months. Two indices (PLBI and sPLBI) were calculated to describe BMI change from pre-pregnancy to 7 months postpartum. Results: Breastfeeding for ≥6 months was significantly associated with marital status, mode of delivery, lower BMI on postpartum day 2, and a positive change in the overhydration index (ΔOH). Women in this group exhibited significantly lower PLBI and sPLBI values, indicating more effective postpartum weight recovery and a greater return toward pre-pregnancy BMI. Hydration parameters derived from BIA differentiated between shorter and longer breastfeeding duration. Conclusions: Positive postpartum hydration balance (ΔOH ≥ 0) and efficient metabolic recovery, reflected by lower PLBI and sPLBI values, may support longer breastfeeding. BIA-based assessment of hydration and body composition could help identify women at higher risk of early breastfeeding cessation. Further longitudinal research is warranted to confirm the clinical utility of BIA in postpartum care and its potential role in early lactation support.
Pregnancy is a physiological state of transient, reversible insulin resistance accompanied by major adaptations in glucose and lipid metabolism. Although placental hormones are key drivers of gestational insulin resistance, the mechanisms underlying the rapid restoration of insulin sensitivity after delivery remain incompletely understood. This review proposes a conceptual framework in which fibroblast growth factor 21 (FGF21) and sex hormone-binding globulin (SHBG) are considered as complementary hepatic signals potentially involved in maternal metabolic adaptation. During late pregnancy, FGF21 may function as a metabolic stress-response factor associated with fatty acid oxidation, lipid handling, and mitochondrial adaptation through AMPK–PPARα-related pathways. Reduced SHBG, in contrast, may reflect hepatic insulin resistance and altered hepatic metabolic regulation. After delivery, changes in FGF21 and SHBG levels may be associated with recovery of hepatic metabolic homeostasis and insulin sensitivity, while persistent adaptive FGF21 signaling facilitate metabolic reprogramming may contribute to ongoing metabolic adaptation. Postpartum metabolic recovery may therefore represent an active and dynamic process rather than a purely passive consequence of placental hormone withdrawal. Disruption of FGF21- and SHBG-mediated pathways may contribute to persistent insulin resistance and increased cardiometabolic risk after gestational diabetes. Understanding hepatokine-mediated regulation of maternal metabolic flexibility may provide further insight into postpartum metabolic recovery and may support future development of risk stratification strategies, biomarker-based approaches, and preventive interventions aimed at reducing the risk of type 2 diabetes after pregnancy.